Michael Crawford, MD

Chief of Clinical Cardiology

Dr. Michael Crawford, chief of clinical cardiology at UCSF Medical Center, specializes in treating coronary artery disease, valvular heart disease and heart failure as well as congenital heart disease in adults and heart disease in athletes.

Crawford earned a medical degree at the University of California, San Francisco. He trained in internal medicine at UCSF Medical Center and Beth Israel Hospital in Boston, followed by cardiology training at the University of California, San Diego, where he joined the faculty. He was co-director of cardiology at the University of Texas in San Antonio and chief of cardiology at the University of New Mexico in Albuquerque. Before returning to UCSF, Crawford was a consultant and vice chair of cardiology at the Mayo Clinic in Scottsdale, Ariz. Crawford has served as chair of the Council on Clinical Cardiology of the American Heart Association and as a board member of the American College of Cardiology. He is a fellow of the American College of Physicians and a member of the Association of University Cardiologists and Western Association of Physicians.


Cardiovascular Care and Prevention Center at Mission Bay
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

  • Athlete's Heart
  • Valvular Heart Disease

Academic Title


More about Michael Crawford


UCSF School of Medicine 1969


UCSF Medical Center, Internal Medicine 1971
Beth Israel Deaconess Medical Center, Internal Medicine 1972


UC San Diego Hospital, Cardiology 1974

Selected Research and Publications

  1. Hou L, Kember RL, Roach JC, O'Connell JR, Craig DW, Bucan M, Scott WK, Pericak-Vance M, Haines JL, Crawford MH, Shuldiner AR, McMahon FJ. Author Correction: A population-specific reference panel empowers genetic studies of Anabaptist populations. Sci Rep. 2018 Apr 25; 8(1):6771.
  2. Zhao SX, Kwong C, Swaminathan A, Gohil A, Crawford MH. Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy. JACC Heart Fail. 2018 Mar; 6(3):209-218.
  3. Fagundes NJR, Tagliani-Ribeiro A, Rubicz R, Tarskaia L, Crawford MH, Salzano FM, Bonatto SL. How strong was the bottleneck associated to the peopling of the Americas? New insights from multilocus sequence data. Genet Mol Biol. 2018; 41(1 suppl 1):206-214.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.